Delivery Order SPE2DB24D1201-SPE2DB24FJBAP
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of Clindamycin Phosphate 1% Foam, 50GM, to the Defense Logistics Agency (DLA). The contract, valued at $1,267.50, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 2, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $1,130.90 firm-fixed-price delivery order contract has a completion date of May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,458.95, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 14, 2025, with a performance period extending to May 15, 2025. The contract is not designated as a set-aside and was awarded under the DLA's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $10,526.66 for the provision of Clindamycin Phosphate 1% Foam 100GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 4, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, 100 grams, with a ceiling value of $1,811.64 and a period of performance through June 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,758.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHLH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.14 firm fixed price delivery order is for the supply of 4567174426 - Clindamycin Phosphate 1% Foam, 100GM. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,334.32 firm fixed-price delivery order contract is for the supply of 4567691064 - CLINDAMYCIN PHOSPHATE 1% FOAM 50GM. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,249.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of November 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $4,744.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...